ERAL1 and breast neoplasm: Finally, accounting for differential expression of ER-α and other hypoxia sensitive molecules in hypoxic regions of tumors offers one explanation for the intra-tumor heterogeneity of ER-α expression seen in many clinical breast tumor sections.